In this research, we demonstrated that FACT is a potential therapeutic target for B-NHL, and both SSRP1 and SUPT16H are significantly overexpressed in DLBCL tumor tissues and are closely related. Here, SSRP1 is linked to diffuse large B-cell lymphoma.